# AgilVax

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/agilvax

- Industry: Biotechnology
- Headquarters: Albuquerque, US
- Website: www.agilvax.com
- Total disclosed funding: $1.6M
- Latest round: Series A (May 10, 2018)
- Investors on record: 2

## About

Founded in 2011 and based in New Mexico, US, AgilVax, Inc. operates as a biotechnology company that develops AX09, antibody-based therapy used for cancer treatment.

## Funding rounds

- Series A, May 10, 2018, $0.5M — Sun Mountain Capital, J. Hunt Holdings
- Series A, Jun 11, 2014, $1.1M — Sun Mountain Capital, J. Hunt Holdings

## Investors

- Sun Mountain Capital (https://capitalatlas.ai/funds/sun-mountain-capital) — Series A
- J. Hunt Holdings (https://capitalatlas.ai/funds/j-hunt-holdings) — Series A